The Enterprise Value as of December 2025 (TTM) for Seres Therapeutics, Inc. (MCRB) is 194.69M

According to Seres Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 194.69M. This represents a change of 13.40% compared to the average of 171.68M of the last 4 quarters.

Seres Therapeutics, Inc. (MCRB) Historical Enterprise Value (quarterly & annually)

How has MCRB Enterprise Value performed in the past?

The mean historical Enterprise Value of Seres Therapeutics, Inc. over the last ten years is 8.29B. The current 194.69M Enterprise Value has changed 134.88% with respect to the historical average. Over the past ten years (40 quarters), MCRB's Enterprise Value was at its highest in in the December 2015 quarter at 16.51T. The Enterprise Value was at its lowest in in the June 2025 quarter at 139.20M.

Seres Therapeutics, Inc. (MCRB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Seres Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seres Therapeutics, Inc. (MCRB) Average Enterprise Value

How has MCRB Enterprise Value performed in the past?

The current Enterprise Value of Seres Therapeutics, Inc. (MCRB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Seres Therapeutics, Inc. (MCRB) Enterprise Value vs. Peers

How is MCRB’s Enterprise Value compared to its peers?

Seres Therapeutics, Inc.’s Enterprise Value is greater than Spero Therapeutics, Inc. (83.18M), greater than VistaGen Therapeutics, Inc. (78.69M), greater than Actuate Therapeutics Inc (153.91M), greater than Inovio Pharmaceuticals, Inc. (94.56M), greater than Acumen Pharmaceuticals, Inc. (76.70M), greater than Seer, Inc. (86.40M), greater than Opus Genetics, Inc. (121.30M), greater than Cognition Therapeutics, Inc. (119.19M), greater than TuHURA Biosciences, Inc. (92.82M), greater than Applied Therapeutics, Inc. (23.64M),

Build a custom stock screener for Seres Therapeutics, Inc. (MCRB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seres Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seres Therapeutics, Inc. (MCRB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seres Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.